2025-524725-41-00招募中1 期
Single-centre Phase I/II study with dose escalation of tocilizumab in combination with venetoclax and azacitidine chemotherapy in patients with Acute Myeloid Leukaemia (AML): TOCIVENA
Centre Hospitalier Universitaire De Nantes2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2026年2月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Study Coordinator
Scientific
Centre Hospitalier Universitaire De Nantes
研究点 (2)
Loading locations...
相似试验
招募中
1/2 期
A phase I dose-escalation study testing the feasibility and the tolerance of infusion of a third party suicide gene-transduced anti-HLA-DPB1*0401 cytotoxic T cell clone in patients with HLA-DPB1*0401 positive hematologic malignancies and receiving an allotransplant from HLA-DPB1*0401 negative donors2024-515504-39-00Centre Hospitalier Universitaire De Nantes6
已完成
1 期
A first in human single dose escalation study to investigate the safety, tolerability, pharmacokinetics, and pharmcodynamics of BAY 3389934 compared with placebo.2022-502866-25-00Bayer AG86
招募中
1 期
A Phase I Study of SY-9453 in Patients With Advanced Solid TumorsNCT07469982Shouyao Holdings (Beijing) Co. LTD122
招募中
1 期
A Phase 1, First-in-Human, Dose Escalation Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms2024-514341-10-00Janssen Cilag International64
尚未招募
1 期
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid TumorsNCT07487168H. Lee Moffitt Cancer Center and Research Institute24